Virtus ETF Advisers’s Rocket Pharmaceuticals RCKT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-5,656
Closed -$71.1K 578
2024
Q4
$71.1K Buy
5,656
+1,628
+40% +$20.5K 0.03% 363
2024
Q3
$74.4K Buy
4,028
+68
+2% +$1.26K 0.03% 419
2024
Q2
$85.3K Buy
3,960
+897
+29% +$19.3K 0.04% 381
2024
Q1
$82.5K Sell
3,063
-211
-6% -$5.68K 0.04% 389
2023
Q4
$98.1K Sell
3,274
-1,082
-25% -$32.4K 0.06% 367
2023
Q3
$89.3K Sell
4,356
-436
-9% -$8.93K 0.05% 349
2023
Q2
$95.2K Buy
4,792
+351
+8% +$6.97K 0.06% 407
2023
Q1
$76.1K Sell
4,441
-1,713
-28% -$29.3K 0.04% 391
2022
Q4
$120K Sell
6,154
-3,706
-38% -$72.5K 0.06% 413
2022
Q3
$157K Buy
9,860
+68
+0.7% +$1.08K 0.06% 347
2022
Q2
$135K Buy
9,792
+3,000
+44% +$41.4K 0.05% 339
2022
Q1
$108K Sell
6,792
-400
-6% -$6.36K 0.05% 290
2021
Q4
$157K Buy
7,192
+2,686
+60% +$58.6K 0.06% 336
2021
Q3
$135K Sell
4,506
-228
-5% -$6.83K 0.06% 358
2021
Q2
$210K Sell
4,734
-627
-12% -$27.8K 0.09% 312
2021
Q1
$238K Buy
5,361
+100
+2% +$4.44K 0.1% 296
2020
Q4
$289K Sell
5,261
-11,734
-69% -$645K 0.12% 230
2020
Q3
$389K Sell
16,995
-2,315
-12% -$53K 0.2% 174
2020
Q2
$404K Buy
19,310
+2,895
+18% +$60.6K 0.19% 193
2020
Q1
$229K Sell
16,415
-2,391
-13% -$33.4K 0.09% 269
2019
Q4
$428K Buy
18,806
+3,143
+20% +$71.5K 0.07% 235
2019
Q3
$182K Sell
15,663
-872
-5% -$10.1K 0.04% 261
2019
Q2
$248K Sell
16,535
-1,264
-7% -$19K 0.05% 277
2019
Q1
$312K Sell
17,799
-1,805
-9% -$31.6K 0.66% 57
2018
Q4
$291K Sell
19,604
-2,170
-10% -$32.2K 0.05% 119
2018
Q3
$536K Sell
21,774
-15,976
-42% -$393K 0.06% 113
2018
Q2
$741K Buy
+37,750
New +$741K 0.66% 75